Viz.ai Stock
Viz.ai is a prominent AI care coordination platform designed to enhance disease detection and optimize workflow in healthcare settings. The company leverages advanced artificial intelligence algorithms to analyze medical imaging data, including CT scans and EKGs, providing real-time insights that facilitate faster diagnosis and treatment.
Sign up for SecondMarket™ to view the market and buy or sell Viz.ai Stock
Buy + SellViz.ai Funding
Sign up to gain insights into Viz.ai funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Apr 07, 2022 | Series D | 100.00M | ||
Mar 05, 2021 | Series C | 71.00M | ||
Oct 23, 2019 | Series B | 50.00M | ||
Jun 13, 2018 | Series A | 20.80M | ||
May 09, 2017 | Series Seed | 4.77M | ||
Sep 15, 2016 | Series Seed | 2.49M |
See Viz.ai Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Viz.ai Stock Valuation + Share Prices
View real-time Tape D™ data on Viz.ai stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedViz.ai Management Team
Director
Steve Mnuchin
CTO
Sanjay Parmar
Co-Founder, CTO
David Tsao
Director
Marc Elia
CRO
John Siebert
Chief Revenue Officer
Michael Rolla
Director
Josh Breinlinger
Co-Founder, Director
Daniel Saks
Director
Nick Shalek
Director
David Wu